APP AppLovin | $272.00
+2.7% | 3/27/2025 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | | High | View details for Oppenheimer rating of AppLovin (NASDAQ:APP) on 3/27/2025 |
OUST Ouster | $8.73
-2.8% | 3/27/2025 | Initiated by | Oppenheimer | Analyst Colin Rusch | Outperform | $16.00 | High | View details for Oppenheimer rating of Ouster (NYSE:OUST) on 3/27/2025 |
AUR Aurora Innovation | $6.64
-1.4% | 3/27/2025 | Initiated by | Oppenheimer | Analyst Colin Rusch | Outperform | $15.00 | High | View details for Oppenheimer rating of Aurora Innovation (NASDAQ:AUR) on 3/27/2025 |
BMEA Biomea Fusion | $2.08
-2.4% | 3/24/2025 | Target Set by | Oppenheimer | - | | $10.00 | Low | View details for Oppenheimer rating of Biomea Fusion (NASDAQ:BMEA) on 3/24/2025 |
CRVS Corvus Pharmaceuticals | $3.20
+0.5% | 3/26/2025 | Reiterated by | Oppenheimer | Analyst Jeff Jones | Outperform -> Outperform | $14.00 -> $15.00 | Low | View details for Oppenheimer rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 3/26/2025 |
ZURA Zura Bio | $1.18
-8.4% | 3/26/2025 | Reiterated by | Oppenheimer | Analyst Jeff Jones | Outperform -> Outperform | $20.00 -> $19.00 | Medium | View details for Oppenheimer rating of Zura Bio (NASDAQ:ZURA) on 3/26/2025 |
OPT Opthea | $3.41
+7.2% | 3/24/2025 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | N/A | View details for Oppenheimer rating of Opthea (NASDAQ:OPT) on 3/24/2025 |
QNCX Quince Therapeutics | $1.28
-4.0% | 3/24/2025 | Initiated by | Oppenheimer | Analyst Leland Gershell | Outperform | $10.00 | High | View details for Oppenheimer rating of Quince Therapeutics (NASDAQ:QNCX) on 3/24/2025 |
FDX FedEx | $241.02
-1.1% | 3/21/2025 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of FedEx (NYSE:FDX) on 3/21/2025 |
ASO Academy Sports and Outdoors | $46.60
+2.2% | 3/21/2025 | Target Lowered by | Oppenheimer | Analyst Brian Nagel | Outperform -> Outperform | $85.00 -> $70.00 | Medium | View details for Oppenheimer rating of Academy Sports and Outdoors (NASDAQ:ASO) on 3/21/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
AMPX Amprius Technologies | $2.56
-4.7% | 3/21/2025 | Target Raised by | Oppenheimer | Analyst Colin Rusch | Outperform -> Outperform | $14.00 -> $15.00 | High | View details for Oppenheimer rating of Amprius Technologies (NYSE:AMPX) on 3/21/2025 |
MPWR Monolithic Power Systems | $583.06
+0.5% | 3/21/2025 | Reiterated by | Oppenheimer | Analyst Rick Schafer | Outperform -> Outperform | $800.00 -> $800.00 | High | View details for Oppenheimer rating of Monolithic Power Systems (NASDAQ:MPWR) on 3/21/2025 |
VOR Vor Biopharma | $0.65
-9.1% | 3/21/2025 | Reiterated by | Oppenheimer | Analyst Matthew Biegler | Outperform -> Outperform | $8.00 -> $8.00 | High | View details for Oppenheimer rating of Vor Biopharma (NYSE:VOR) on 3/21/2025 |
DRI Darden Restaurants | $207.71
0.0% | 3/21/2025 | Target Raised by | Oppenheimer | Analyst Brian Bittner | Outperform -> Outperform | $218.00 -> $230.00 | Medium | View details for Oppenheimer rating of Darden Restaurants (NYSE:DRI) on 3/21/2025 |
FSLY Fastly | $6.38
+0.7% | 3/20/2025 | Initiated by | Oppenheimer | - | Market Perform | | Low | View details for Oppenheimer rating of Fastly (NYSE:FSLY) on 3/20/2025 |
NET Cloudflare | $113.37
+0.6% | 3/20/2025 | Initiated by | Oppenheimer | - | Outperform | $150.00 | Low | View details for Oppenheimer rating of Cloudflare (NYSE:NET) on 3/20/2025 |
LRCX Lam Research | $72.20
-0.7% | 3/20/2025 | Initiated by | Oppenheimer | - | Outperform | $95.00 | Low | View details for Oppenheimer rating of Lam Research (NASDAQ:LRCX) on 3/20/2025 |
AKAM Akamai Technologies | $80.46
-0.1% | 3/20/2025 | Initiated by | Oppenheimer | Analyst Param Singh | Outperform | $116.00 -> $100.00 | Low | View details for Oppenheimer rating of Akamai Technologies (NASDAQ:AKAM) on 3/20/2025 |
AEVA Aeva Technologies | $7.21
+3.0% | 3/20/2025 | Target Raised by | Oppenheimer | Analyst Colin Rusch | Outperform -> Outperform | $5.00 -> $6.00 | High | View details for Oppenheimer rating of Aeva Technologies (NYSE:AEVA) on 3/20/2025 |
MOS Mosaic | $26.69
-1.2% | 3/20/2025 | Upgraded by | Oppenheimer | Analyst Kristen Owen | Market Perform -> Outperform | $33.00 -> $33.00 | Medium | View details for Oppenheimer rating of Mosaic (NYSE:MOS) on 3/20/2025 |
CDNS Cadence Design Systems | $256.20
+0.7% | 3/19/2025 | Target Lowered by | Oppenheimer | Analyst Edward Yang | Underperform -> Underperform | $225.00 -> $200.00 | Medium | View details for Oppenheimer rating of Cadence Design Systems (NASDAQ:CDNS) on 3/19/2025 |
OLMA Olema Pharmaceuticals | $3.57
-5.1% | 3/19/2025 | Reiterated by | Oppenheimer | Analyst Matthew Biegler | Outperform -> Outperform | $30.00 -> $25.00 | High | View details for Oppenheimer rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 3/19/2025 |
JEF Jefferies Financial Group | $53.12
-0.8% | 3/19/2025 | Downgraded by | Oppenheimer | Analyst Chris Kotowski | Outperform -> Market Perform | | High | View details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 3/19/2025 |
GS The Goldman Sachs Group | $546.50
+0.0% | 3/19/2025 | Downgraded by | Oppenheimer | Analyst Chris Kotowski | Outperform -> Market Perform | | Medium | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 3/19/2025 |
CG The Carlyle Group | $43.63
+0.1% | 3/19/2025 | Downgraded by | Oppenheimer | Analyst Chris Kotowski | Outperform -> Market Perform | | High | View details for Oppenheimer rating of The Carlyle Group (NASDAQ:CG) on 3/19/2025 |
TSLA Tesla | $271.88
+4.9% | 3/18/2025 | Reiterated by | Oppenheimer | - | Mixed -> Mixed | | Medium | View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 3/18/2025 |
EXPE Expedia Group | $165.27
-1.7% | 3/17/2025 | Target Lowered by | Oppenheimer | Analyst Jed Kelly | Outperform -> Outperform | $235.00 -> $230.00 | Low | View details for Oppenheimer rating of Expedia Group (NASDAQ:EXPE) on 3/17/2025 |
PHAR Pharming Group | $8.21
-1.9% | 3/14/2025 | Target Raised by | Oppenheimer | Analyst Michael Carrier | Outperform -> Outperform | $30.00 -> $39.00 | Low | View details for Oppenheimer rating of Pharming Group (NASDAQ:PHAR) on 3/14/2025 |
EVCM EverCommerce | $10.12
+0.4% | 3/14/2025 | Target Lowered by | Oppenheimer | Analyst Brian Schwartz | Outperform -> Outperform | $13.00 -> $12.00 | High | View details for Oppenheimer rating of EverCommerce (NASDAQ:EVCM) on 3/14/2025 |
NKTR Nektar Therapeutics | $0.66
-2.6% | 3/14/2025 | Upgraded by | Oppenheimer | Analyst Jay Olson | Market Perform -> Outperform | $6.00 | High | View details for Oppenheimer rating of Nektar Therapeutics (NASDAQ:NKTR) on 3/14/2025 |
ADBE Adobe | $379.06
-1.2% | 3/13/2025 | Target Lowered by | Oppenheimer | Analyst Brian Schwartz | Outperform -> Outperform | $560.00 -> $530.00 | High | View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 3/13/2025 |
FERG Ferguson | $160.31
+0.0% | 3/12/2025 | Target Lowered by | Oppenheimer | Analyst Scott Schneeberger | Outperform -> Outperform | $234.00 -> $189.00 | Low | View details for Oppenheimer rating of Ferguson (NASDAQ:FERG) on 3/12/2025 |
ARVN Arvinas | $7.17
+2.1% | 3/11/2025 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Medium | View details for Oppenheimer rating of Arvinas (NASDAQ:ARVN) on 3/11/2025 |
TRVI Trevi Therapeutics | $6.03
-4.1% | 3/11/2025 | Target Raised by | Oppenheimer | Analyst Leland Gershell | Outperform -> Outperform | $12.00 -> $20.00 | High | View details for Oppenheimer rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/11/2025 |
OKUR OnKure Therapeutics | $4.15
-3.6% | 3/11/2025 | Target Lowered by | Oppenheimer | Analyst Matt Biegler | Outperform -> Outperform | $35.00 -> $30.00 | High | View details for Oppenheimer rating of OnKure Therapeutics (NASDAQ:OKUR) on 3/11/2025 |
FRPT Freshpet | $82.93
-0.3% | 3/11/2025 | Downgraded by | Oppenheimer | Analyst Rupesh Parikh | Outperform -> Market Perform | | High | View details for Oppenheimer rating of Freshpet (NASDAQ:FRPT) on 3/11/2025 |
DASH DoorDash | $180.83
-1.1% | 3/10/2025 | Reiterated by | Oppenheimer | - | Hold -> Hold | | Low | View details for Oppenheimer rating of DoorDash (NASDAQ:DASH) on 3/10/2025 |
DASH DoorDash | $180.83
-1.1% | 3/3/2025 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | | High | View details for Oppenheimer rating of DoorDash (NASDAQ:DASH) on 3/3/2025 |
WSC WillScot Mobile Mini | $27.66
-0.5% | 3/10/2025 | Target Lowered by | Oppenheimer | Analyst Scott Schneeberger | Outperform -> Outperform | $41.00 -> $38.00 | High | View details for Oppenheimer rating of WillScot Mobile Mini (NASDAQ:WSC) on 3/10/2025 |
CNNE Cannae | $18.55
+1.2% | 3/7/2025 | Target Lowered by | Oppenheimer | Analyst Ian Zaffino | Outperform -> Outperform | $27.00 -> $22.00 | Low | View details for Oppenheimer rating of Cannae (NYSE:CNNE) on 3/7/2025 |
Partner with Elon Musk on Project Colossus… Before May 1st (Ad) Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you…
To partner with Elon on what he believes will be the biggest AI project of the century…
Starting with as little as $500. Click here to see how you could take a stake in Elon’s private company… |
TGT Target | $104.46
+0.1% | 3/6/2025 | Target Lowered by | Oppenheimer | Analyst Rupesh Parikh | Outperform -> Outperform | $165.00 -> $150.00 | Medium | View details for Oppenheimer rating of Target (NYSE:TGT) on 3/6/2025 |
CTOS Custom Truck One Source | $4.20
-0.6% | 3/6/2025 | Target Raised by | Oppenheimer | Analyst Scott Schneeberger | Outperform -> Outperform | $5.00 -> $6.00 | High | View details for Oppenheimer rating of Custom Truck One Source (NYSE:CTOS) on 3/6/2025 |
MDB MongoDB | $176.19
+0.5% | 3/6/2025 | Target Lowered by | Oppenheimer | Analyst Ittai Kidron | Outperform -> Outperform | $400.00 -> $330.00 | High | View details for Oppenheimer rating of MongoDB (NASDAQ:MDB) on 3/6/2025 |
ABEO Abeona Therapeutics | $4.54
-4.7% | 3/5/2025 | Initiated by | Oppenheimer | Analyst Francois Brisebois | Outperform | $16.00 | Medium | View details for Oppenheimer rating of Abeona Therapeutics (NASDAQ:ABEO) on 3/5/2025 |
OKTA Okta | $104.62
-0.6% | 3/4/2025 | Target Raised by | Oppenheimer | Analyst Shaul Eyal | Outperform -> Outperform | $125.00 -> $135.00 | High | View details for Oppenheimer rating of Okta (NASDAQ:OKTA) on 3/4/2025 |
MRCC Monroe Capital | $7.71
-1.2% | 3/4/2025 | Target Lowered by | Oppenheimer | Analyst Chris Kotowski | Market Perform -> Market Perform | $9.00 -> $8.00 | Medium | View details for Oppenheimer rating of Monroe Capital (NASDAQ:MRCC) on 3/4/2025 |
GILD Gilead Sciences | $111.47
-0.5% | 3/4/2025 | Target Raised by | Oppenheimer | Analyst Hartaj Singh | Outperform -> Outperform | $115.00 -> $132.00 | High | View details for Oppenheimer rating of Gilead Sciences (NASDAQ:GILD) on 3/4/2025 |
DNLI Denali Therapeutics | $12.64
-7.1% | 3/3/2025 | Target Lowered by | Oppenheimer | Analyst Jay Olson | Outperform -> Outperform | $50.00 -> $42.00 | High | View details for Oppenheimer rating of Denali Therapeutics (NASDAQ:DNLI) on 3/3/2025 |
ARGX argenx | $584.20
-1.3% | 2/28/2025 | Target Raised by | Oppenheimer | Analyst Leland Gershell | Outperform -> Outperform | $675.00 -> $704.00 | Low | View details for Oppenheimer rating of argenx (NASDAQ:ARGX) on 2/28/2025 |
ARRY Array Technologies | $4.85
-0.5% | 2/28/2025 | Target Lowered by | Oppenheimer | Analyst Colin Rusch | Outperform -> Outperform | $14.00 -> $13.00 | N/A | View details for Oppenheimer rating of Array Technologies (NASDAQ:ARRY) on 2/28/2025 |
LMAT LeMaitre Vascular | $84.33
+0.5% | 2/28/2025 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | High | View details for Oppenheimer rating of LeMaitre Vascular (NASDAQ:LMAT) on 2/28/2025 |
IAS Integral Ad Science | $7.98
-1.1% | 2/28/2025 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | | High | View details for Oppenheimer rating of Integral Ad Science (NASDAQ:IAS) on 2/28/2025 |
SG Sweetgreen | $25.28
+1.0% | 2/27/2025 | Target Lowered by | Oppenheimer | Analyst Brian Bittner | Outperform -> Outperform | $41.00 -> $35.00 | High | View details for Oppenheimer rating of Sweetgreen (NYSE:SG) on 2/27/2025 |
IGIC International General Insurance | $26.65
+1.3% | 2/27/2025 | Target Raised by | Oppenheimer | Analyst Michael Phillips | Outperform -> Outperform | $30.00 -> $32.00 | High | View details for Oppenheimer rating of International General Insurance (NASDAQ:IGIC) on 2/27/2025 |
NTNX Nutanix | $68.91
-1.3% | 2/27/2025 | Target Raised by | Oppenheimer | Analyst Param Singh | Outperform -> Outperform | $90.00 -> $100.00 | High | View details for Oppenheimer rating of Nutanix (NASDAQ:NTNX) on 2/27/2025 |
CRM Salesforce | $269.16
+0.3% | 2/27/2025 | Target Lowered by | Oppenheimer | Analyst Brian Schwartz | Outperform -> Outperform | $415.00 -> $380.00 | Low | View details for Oppenheimer rating of Salesforce (NYSE:CRM) on 2/27/2025 |
SNOW Snowflake | $147.67
+1.0% | 2/27/2025 | Target Raised by | Oppenheimer | Analyst Ittai Kidron | Outperform -> Outperform | $200.00 -> $220.00 | High | View details for Oppenheimer rating of Snowflake (NYSE:SNOW) on 2/27/2025 |
BSY Bentley Systems | $39.97
+1.6% | 2/27/2025 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Bentley Systems (NASDAQ:BSY) on 2/27/2025 |
GB Global Blue Group | $7.37
+0.1% | 2/27/2025 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Global Blue Group (NYSE:GB) on 2/27/2025 |
TBLA Taboola.com | $3.02
+2.2% | 2/26/2025 | Reiterated by | Oppenheimer | - | Outperform -> Market Perform | | Medium | View details for Oppenheimer rating of Taboola.com (NASDAQ:TBLA) on 2/26/2025 |
ITRI Itron | $105.28
+0.5% | 2/26/2025 | Target Raised by | Oppenheimer | Analyst Noah Kaye | Outperform -> Outperform | $124.00 -> $131.00 | Low | View details for Oppenheimer rating of Itron (NASDAQ:ITRI) on 2/26/2025 |
CART Maplebear | $39.99
+0.2% | 2/26/2025 | Target Lowered by | Oppenheimer | Analyst Jason Helfstein | Outperform -> Outperform | $65.00 -> $60.00 | High | View details for Oppenheimer rating of Maplebear (NASDAQ:CART) on 2/26/2025 |
PRCH Porch Group | $7.37
+1.1% | 2/26/2025 | Target Raised by | Oppenheimer | Analyst Jason Helfstein | Outperform -> Outperform | $7.00 -> $8.00 | High | View details for Oppenheimer rating of Porch Group (NASDAQ:PRCH) on 2/26/2025 |
SPXC SPX Technologies | $130.46
+1.3% | 2/26/2025 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $165.00 | High | View details for Oppenheimer rating of SPX Technologies (NYSE:SPXC) on 2/26/2025 |
WDAY Workday | $232.19
-0.6% | 2/26/2025 | Target Raised by | Oppenheimer | Analyst Brian Schwartz | Outperform -> Outperform | $300.00 -> $320.00 | High | View details for Oppenheimer rating of Workday (NASDAQ:WDAY) on 2/26/2025 |
CARG CarGurus | $29.08
-0.2% | 2/24/2025 | Target Lowered by | Oppenheimer | Analyst Jed Kelly | Outperform -> Outperform | $44.00 -> $42.00 | High | View details for Oppenheimer rating of CarGurus (NASDAQ:CARG) on 2/24/2025 |
FRPT Freshpet | $82.93
-0.3% | 2/24/2025 | Target Lowered by | Oppenheimer | Analyst Rupesh Parikh | Outperform -> Outperform | $180.00 -> $140.00 | High | View details for Oppenheimer rating of Freshpet (NASDAQ:FRPT) on 2/24/2025 |
BMRN BioMarin Pharmaceutical | $69.46
-1.7% | 2/24/2025 | Upgraded by | Oppenheimer | Analyst Leland Gershell | Market Perform -> Outperform | $98.00 | Low | View details for Oppenheimer rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 2/24/2025 |
COIN Coinbase Global | $173.07
+0.5% | 2/10/2025 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | | High | View details for Oppenheimer rating of Coinbase Global (NASDAQ:COIN) on 2/10/2025 |
V Visa | $345.04
-1.5% | 2/13/2025 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | | N/A | View details for Oppenheimer rating of Visa (NYSE:V) on 2/13/2025 |
ITGR Integer | $118.86
+0.7% | 2/21/2025 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | High | View details for Oppenheimer rating of Integer (NYSE:ITGR) on 2/21/2025 |
TOL Toll Brothers | $105.42
-0.2% | 2/20/2025 | Target Lowered by | Oppenheimer | Analyst Tyler Batory | Outperform -> Outperform | $189.00 -> $165.00 | Low | View details for Oppenheimer rating of Toll Brothers (NYSE:TOL) on 2/20/2025 |
TRMB Trimble | $65.27
-0.6% | 2/20/2025 | Target Raised by | Oppenheimer | Analyst Kristen Owen | Outperform -> Outperform | $88.00 -> $90.00 | Low | View details for Oppenheimer rating of Trimble (NASDAQ:TRMB) on 2/20/2025 |
ADI Analog Devices | $197.68
-2.0% | 2/20/2025 | Reiterated by | Oppenheimer | Analyst Rick Schafer | Outperform -> Outperform | $245.00 -> $270.00 | Low | View details for Oppenheimer rating of Analog Devices (NASDAQ:ADI) on 2/20/2025 |
CLH Clean Harbors | $198.83
+0.9% | 2/20/2025 | Target Lowered by | Oppenheimer | Analyst Noah Kaye | Outperform -> Outperform | $256.00 -> $254.00 | Low | View details for Oppenheimer rating of Clean Harbors (NYSE:CLH) on 2/20/2025 |
CCSI Consensus Cloud Solutions | $22.95
-0.6% | 2/20/2025 | Target Raised by | Oppenheimer | Analyst Ian Zaffino | Outperform -> Outperform | $27.00 -> $32.00 | High | View details for Oppenheimer rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 2/20/2025 |
IFF International Flavors & Fragrances | $77.51
-0.1% | 2/20/2025 | Target Lowered by | Oppenheimer | Analyst Kristen Owen | Outperform -> Outperform | $114.00 -> $104.00 | Medium | View details for Oppenheimer rating of International Flavors & Fragrances (NYSE:IFF) on 2/20/2025 |
ONTO Onto Innovation | $121.66
+0.3% | 2/20/2025 | Target Lowered by | Oppenheimer | Analyst Edward Yang | Outperform -> Outperform | $275.00 -> $240.00 | Low | View details for Oppenheimer rating of Onto Innovation (NYSE:ONTO) on 2/20/2025 |
PRSU Pursuit Attractions & Hospitality | $35.15
-0.7% | 2/20/2025 | Reiterated by | Oppenheimer | Analyst Tyler Batory | Outperform -> Outperform | $54.00 -> $50.00 | Medium | View details for Oppenheimer rating of Pursuit Attractions & Hospitality (NYSE:PRSU) on 2/20/2025 |
FOUR Shift4 Payments | $83.60
+2.3% | 2/20/2025 | Target Lowered by | Oppenheimer | Analyst Rayna Kumar | Outperform -> Outperform | $142.00 -> $135.00 | Medium | View details for Oppenheimer rating of Shift4 Payments (NYSE:FOUR) on 2/20/2025 |
SONY Sony Group | $25.03
-1.4% | 2/20/2025 | Reiterated by | Oppenheimer | Analyst Martin Yang | Outperform -> Outperform | $25.00 -> $33.00 | Low | View details for Oppenheimer rating of Sony Group (NYSE:SONY) on 2/20/2025 |
TPH Tri Pointe Homes | $32.08
+0.5% | 2/19/2025 | Target Lowered by | Oppenheimer | Analyst Tyler Batory | Outperform -> Outperform | $53.00 -> $43.00 | Low | View details for Oppenheimer rating of Tri Pointe Homes (NYSE:TPH) on 2/19/2025 |
COMP Compass | $8.82
+1.0% | 2/19/2025 | Target Raised by | Oppenheimer | Analyst Jason Helfstein | Outperform -> Outperform | $12.00 -> $13.00 | High | View details for Oppenheimer rating of Compass (NYSE:COMP) on 2/19/2025 |
BKSY BlackSky Technology | $7.63
-1.4% | 2/19/2025 | Target Raised by | Oppenheimer | Analyst Timothy Horan | Outperform -> Outperform | $10.00 -> $30.00 | High | View details for Oppenheimer rating of BlackSky Technology (NYSE:BKSY) on 2/19/2025 |
GXO GXO Logistics | $39.29
+0.5% | 2/18/2025 | Target Lowered by | Oppenheimer | Analyst Scott Schneeberger | Outperform -> Outperform | $67.00 -> $55.00 | Low | View details for Oppenheimer rating of GXO Logistics (NYSE:GXO) on 2/18/2025 |
TTD Trade Desk | $56.81
+3.8% | 2/13/2025 | Target Lowered by | Oppenheimer | Analyst Jason Helfstein | Outperform -> Outperform | $135.00 -> $115.00 | High | View details for Oppenheimer rating of Trade Desk (NASDAQ:TTD) on 2/13/2025 |
ST Sensata Technologies | $24.22
-0.2% | 2/13/2025 | Target Lowered by | Oppenheimer | Analyst Christopher Glynn | Outperform -> Outperform | $44.00 -> $40.00 | Low | View details for Oppenheimer rating of Sensata Technologies (NYSE:ST) on 2/13/2025 |
APP AppLovin | $272.00
+2.7% | 2/13/2025 | Reiterated by | Oppenheimer | Analyst Martin Yang | Outperform -> Outperform | $480.00 -> $560.00 | High | View details for Oppenheimer rating of AppLovin (NASDAQ:APP) on 2/13/2025 |
ATRC AtriCure | $32.75
+1.5% | 2/13/2025 | Target Raised by | Oppenheimer | Analyst Suraj Kalia | Outperform -> Outperform | $36.00 -> $45.00 | High | View details for Oppenheimer rating of AtriCure (NASDAQ:ATRC) on 2/13/2025 |
CME CME Group | $263.99
-0.5% | 2/13/2025 | Target Raised by | Oppenheimer | Analyst Owen Lau | Outperform -> Outperform | $258.00 -> $269.00 | Low | View details for Oppenheimer rating of CME Group (NASDAQ:CME) on 2/13/2025 |
Trump’s Secret Weapon (Ad) Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next.
But here's the truth… This is just the beginning.
Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better.
Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times.
Don't wait for the next crash to wipe you out. Act now. Get Your FREE Presidential Transition Guide Today |
DENN Denny's | $3.81
+3.7% | 2/13/2025 | Target Lowered by | Oppenheimer | Analyst Michael Tames | Outperform -> Outperform | $8.00 -> $7.00 | High | View details for Oppenheimer rating of Denny’s (NASDAQ:DENN) on 2/13/2025 |
EQIX Equinix | $808.31
-0.9% | 2/13/2025 | Target Raised by | Oppenheimer | Analyst Timothy Horan | Outperform -> Outperform | $950.00 -> $975.00 | Medium | View details for Oppenheimer rating of Equinix (NASDAQ:EQIX) on 2/13/2025 |
IAC IAC | $39.01
-15.1% | 2/13/2025 | Target Lowered by | Oppenheimer | Analyst Jason Helfstein | Outperform -> Outperform | $72.00 -> $70.00 | High | View details for Oppenheimer rating of IAC (NASDAQ:IAC) on 2/13/2025 |
PBH Prestige Consumer Healthcare | $87.64
+1.9% | 2/13/2025 | Target Raised by | Oppenheimer | Analyst Rupesh Parikh | Outperform -> Outperform | $87.00 -> $93.00 | Medium | View details for Oppenheimer rating of Prestige Consumer Healthcare (NYSE:PBH) on 2/13/2025 |
HUBS HubSpot | $579.09
+1.4% | 2/13/2025 | Target Raised by | Oppenheimer | Analyst Ken Wong | Outperform -> Outperform | $850.00 -> $900.00 | High | View details for Oppenheimer rating of HubSpot (NYSE:HUBS) on 2/13/2025 |
ARVN Arvinas | $7.17
+2.1% | 2/12/2025 | Target Raised by | Oppenheimer | Analyst Matthew Biegler | Outperform -> Outperform | $40.00 -> $45.00 | Low | View details for Oppenheimer rating of Arvinas (NASDAQ:ARVN) on 2/12/2025 |
DASH DoorDash | $180.83
-1.1% | 2/12/2025 | Target Raised by | Oppenheimer | Analyst Jason Helfstein | Outperform -> Outperform | $180.00 -> $235.00 | High | View details for Oppenheimer rating of DoorDash (NASDAQ:DASH) on 2/12/2025 |
SHOP Shopify | $98.13
+2.8% | 2/12/2025 | Target Raised by | Oppenheimer | Analyst Ken Wong | Outperform -> Outperform | $130.00 -> $150.00 | Medium | View details for Oppenheimer rating of Shopify (NYSE:SHOP) on 2/12/2025 |
FRSH Freshworks | $14.27
+1.1% | 2/12/2025 | Target Raised by | Oppenheimer | Analyst Brian Schwartz | Outperform -> Outperform | $22.00 -> $24.00 | High | View details for Oppenheimer rating of Freshworks (NASDAQ:FRSH) on 2/12/2025 |
ROK Rockwell Automation | $257.89
-0.2% | 2/11/2025 | Target Raised by | Oppenheimer | Analyst Noah Kaye | Outperform -> Outperform | $300.00 -> $320.00 | Low | View details for Oppenheimer rating of Rockwell Automation (NYSE:ROK) on 2/11/2025 |
IBM International Business Machines | $248.41
-0.1% | 2/11/2025 | Initiated by | Oppenheimer | Analyst Param Singh | Outperform | $320.00 | Medium | View details for Oppenheimer rating of International Business Machines (NYSE:IBM) on 2/11/2025 |
PLYA Playa Hotels & Resorts | $13.34
+0.0% | 2/11/2025 | Downgraded by | Oppenheimer | Analyst Tyler Batory | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Playa Hotels & Resorts (NASDAQ:PLYA) on 2/11/2025 |
PLRX Pliant Therapeutics | $1.37
+1.1% | 2/10/2025 | Reiterated by | Oppenheimer | - | Outperform -> Market Perform | | N/A | View details for Oppenheimer rating of Pliant Therapeutics (NASDAQ:PLRX) on 2/10/2025 |
SPRY ARS Pharmaceuticals | $12.65
+0.6% | 2/10/2025 | Initiated by | Oppenheimer | - | Outperform | $40.00 | High | View details for Oppenheimer rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 2/10/2025 |
PINS Pinterest | $31.40
+1.3% | 2/7/2025 | Target Raised by | Oppenheimer | Analyst Jason Helfstein | Outperform -> Outperform | $40.00 -> $50.00 | High | View details for Oppenheimer rating of Pinterest (NYSE:PINS) on 2/7/2025 |
PRTA Prothena | $11.66
-5.9% | 2/7/2025 | Target Raised by | Oppenheimer | Analyst Jay Olson | Outperform -> Outperform | $58.00 -> $62.00 | Low | View details for Oppenheimer rating of Prothena (NASDAQ:PRTA) on 2/7/2025 |
RRX Regal Rexnord | $114.08
+0.2% | 2/7/2025 | Target Lowered by | Oppenheimer | Analyst Christopher Glynn | Outperform -> Outperform | $210.00 -> $190.00 | Low | View details for Oppenheimer rating of Regal Rexnord (NYSE:RRX) on 2/7/2025 |
STEP StepStone Group | $53.10
+1.7% | 2/7/2025 | Target Raised by | Oppenheimer | Analyst Chris Kotowski | Outperform -> Outperform | $81.00 -> $85.00 | Low | View details for Oppenheimer rating of StepStone Group (NASDAQ:STEP) on 2/7/2025 |
VREX Varex Imaging | $11.50
-0.9% | 2/7/2025 | Target Lowered by | Oppenheimer | Analyst Suraj Kalia | Outperform -> Outperform | $30.00 -> $23.00 | High | View details for Oppenheimer rating of Varex Imaging (NASDAQ:VREX) on 2/7/2025 |
VECO Veeco Instruments | $20.15
+0.4% | 2/7/2025 | Reiterated by | Oppenheimer | Analyst Rick Schafer | Outperform -> Outperform | $40.00 -> $35.00 | Low | View details for Oppenheimer rating of Veeco Instruments (NASDAQ:VECO) on 2/7/2025 |
LULU Lululemon Athletica | $279.95
-1.1% | 2/7/2025 | Target Raised by | Oppenheimer | Analyst Brian Nagel | Outperform -> Outperform | $380.00 -> $500.00 | High | View details for Oppenheimer rating of Lululemon Athletica (NASDAQ:LULU) on 2/7/2025 |
AMZN Amazon.com | $192.62
+1.2% | 2/7/2025 | Target Raised by | Oppenheimer | Analyst Jason Helfstein | Outperform -> Outperform | $230.00 -> $260.00 | Low | View details for Oppenheimer rating of Amazon.com (NASDAQ:AMZN) on 2/7/2025 |
AMSC American Superconductor | $18.21
+0.4% | 2/7/2025 | Target Raised by | Oppenheimer | Analyst Colin Rusch | Outperform -> Outperform | $33.00 -> $39.00 | High | View details for Oppenheimer rating of American Superconductor (NASDAQ:AMSC) on 2/7/2025 |
APTV Aptiv | $59.55
+0.1% | 2/7/2025 | Target Raised by | Oppenheimer | Analyst Colin Rusch | Outperform -> Outperform | $83.00 -> $85.00 | Low | View details for Oppenheimer rating of Aptiv (NYSE:APTV) on 2/7/2025 |
BILL BILL | $45.76
-0.3% | 2/7/2025 | Target Lowered by | Oppenheimer | Analyst Ken Wong | Outperform -> Outperform | $110.00 -> $90.00 | High | View details for Oppenheimer rating of BILL (NYSE:BILL) on 2/7/2025 |
CTVA Corteva | $63.46
+0.8% | 2/7/2025 | Target Raised by | Oppenheimer | Analyst Kristen Owen | Outperform -> Outperform | $70.00 -> $72.00 | Low | View details for Oppenheimer rating of Corteva (NYSE:CTVA) on 2/7/2025 |
EFX Equifax | $242.64
-0.4% | 2/7/2025 | Target Lowered by | Oppenheimer | Analyst Owen Lau | Outperform -> Outperform | $286.00 -> $279.00 | Low | View details for Oppenheimer rating of Equifax (NYSE:EFX) on 2/7/2025 |
EXPE Expedia Group | $165.27
-1.7% | 2/7/2025 | Target Raised by | Oppenheimer | Analyst Jed Kelly | Outperform -> Outperform | $210.00 -> $235.00 | High | View details for Oppenheimer rating of Expedia Group (NASDAQ:EXPE) on 2/7/2025 |
NET Cloudflare | $113.37
+0.6% | 2/7/2025 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | High | View details for Oppenheimer rating of Cloudflare (NYSE:NET) on 2/7/2025 |
WMT Walmart | $88.73
+1.1% | 2/5/2025 | Target Raised by | Oppenheimer | Analyst Rupesh Parikh | Outperform -> Outperform | $100.00 -> $110.00 | Low | View details for Oppenheimer rating of Walmart (NYSE:WMT) on 2/5/2025 |
INGR Ingredion | $135.56
+0.9% | 2/5/2025 | Target Lowered by | Oppenheimer | Analyst Kristen Owen | Outperform -> Outperform | $178.00 -> $167.00 | Low | View details for Oppenheimer rating of Ingredion (NYSE:INGR) on 2/5/2025 |
ENPH Enphase Energy | $61.92
-0.2% | 2/5/2025 | Target Raised by | Oppenheimer | Analyst Colin Rusch | Outperform -> Outperform | $101.00 -> $103.00 | High | View details for Oppenheimer rating of Enphase Energy (NASDAQ:ENPH) on 2/5/2025 |
CYBR CyberArk Software | $343.17
+1.5% | 2/5/2025 | Target Raised by | Oppenheimer | Analyst Shaul Eyal | Outperform -> Outperform | $360.00 -> $420.00 | Low | View details for Oppenheimer rating of CyberArk Software (NASDAQ:CYBR) on 2/5/2025 |
KD Kyndryl | $31.92
+1.7% | 2/4/2025 | Target Raised by | Oppenheimer | Analyst Ian Zaffino | Outperform -> Outperform | $37.00 -> $43.00 | High | View details for Oppenheimer rating of Kyndryl (NYSE:KD) on 2/4/2025 |
DOV Dover | $176.09
+0.2% | 1/31/2025 | Reiterated by | Oppenheimer | Analyst Bryan Blair | Outperform -> Outperform | $220.00 -> $225.00 | High | View details for Oppenheimer rating of Dover (NYSE:DOV) on 1/31/2025 |
MPWR Monolithic Power Systems | $583.06
+0.5% | 1/31/2025 | Target Lowered by | Oppenheimer | Analyst Rick Schafer | Outperform -> Outperform | $900.00 -> $800.00 | High | View details for Oppenheimer rating of Monolithic Power Systems (NASDAQ:MPWR) on 1/31/2025 |
PHM PulteGroup | $103.00
+0.2% | 1/31/2025 | Target Lowered by | Oppenheimer | Analyst Tyler Batory | Outperform -> Outperform | $165.00 -> $150.00 | High | View details for Oppenheimer rating of PulteGroup (NYSE:PHM) on 1/31/2025 |
ROP Roper Technologies | $590.71
+0.2% | 1/31/2025 | Target Raised by | Oppenheimer | Analyst Christopher Glynn | Outperform -> Outperform | $630.00 -> $640.00 | High | View details for Oppenheimer rating of Roper Technologies (NYSE:ROP) on 1/31/2025 |
TMUS T-Mobile US | $265.80
-0.3% | 1/31/2025 | Target Raised by | Oppenheimer | Analyst Timothy Horan | Outperform -> Outperform | $250.00 -> $275.00 | Low | View details for Oppenheimer rating of T-Mobile US (NASDAQ:TMUS) on 1/31/2025 |
V Visa | $345.04
-1.5% | 1/31/2025 | Target Raised by | Oppenheimer | Analyst Rayna Kumar | Outperform -> Outperform | $375.00 -> $390.00 | Medium | View details for Oppenheimer rating of Visa (NYSE:V) on 1/31/2025 |
WM Waste Management | $232.82
+0.6% | 1/31/2025 | Target Raised by | Oppenheimer | Analyst Noah Kaye | Outperform -> Outperform | $231.00 -> $237.00 | Low | View details for Oppenheimer rating of Waste Management (NYSE:WM) on 1/31/2025 |
AOS A. O. Smith | $65.36
0.0% | 1/31/2025 | Target Lowered by | Oppenheimer | Analyst Bryan Blair | Outperform -> Outperform | $88.00 -> $84.00 | Low | View details for Oppenheimer rating of A. O. Smith (NYSE:AOS) on 1/31/2025 |
TEAM Atlassian | $212.44
+0.1% | 1/31/2025 | Target Raised by | Oppenheimer | Analyst Ittai Kidron | Outperform -> Outperform | $300.00 -> $380.00 | High | View details for Oppenheimer rating of Atlassian (NASDAQ:TEAM) on 1/31/2025 |
CI The Cigna Group | $331.20
+0.7% | 1/31/2025 | Target Lowered by | Oppenheimer | Analyst Michael Wiederhorn | Outperform -> Outperform | $400.00 -> $375.00 | Medium | View details for Oppenheimer rating of The Cigna Group (NYSE:CI) on 1/31/2025 |
GOOG Alphabet | $159.01
+1.8% | 1/30/2025 | Target Raised by | Oppenheimer | Analyst Jason Helfstein | Outperform -> Outperform | $215.00 -> $225.00 | Low | View details for Oppenheimer rating of Alphabet (NASDAQ:GOOG) on 1/30/2025 |
META Meta Platforms | $585.93
+1.7% | 1/30/2025 | Target Raised by | Oppenheimer | Analyst Jason Helfstein | Outperform -> Outperform | $650.00 -> $800.00 | Low | View details for Oppenheimer rating of Meta Platforms (NASDAQ:META) on 1/30/2025 |
NOW ServiceNow | $802.49
+0.8% | 1/30/2025 | Target Raised by | Oppenheimer | Analyst Brian Schwartz | Outperform -> Outperform | $1,150.00 -> $1,200.00 | High | View details for Oppenheimer rating of ServiceNow (NYSE:NOW) on 1/30/2025 |
ALMS Alumis | $6.89
+12.2% | 1/30/2025 | Initiated by | Oppenheimer | Analyst Jeff Jones | Outperform | $32.00 | Medium | View details for Oppenheimer rating of Alumis (NASDAQ:ALMS) on 1/30/2025 |
OVID Ovid Therapeutics | $0.32
+2.6% | 1/29/2025 | Upgraded by | Oppenheimer | Analyst Francois Brisebois | Market Perform -> Outperform | $4.00 | Low | View details for Oppenheimer rating of Ovid Therapeutics (NASDAQ:OVID) on 1/29/2025 |
SGHC Super Group | $6.50
+0.9% | 1/29/2025 | Target Raised by | Oppenheimer | Analyst Jed Kelly | Outperform -> Outperform | $9.00 -> $11.00 | Low | View details for Oppenheimer rating of Super Group (NYSE:SGHC) on 1/29/2025 |
Partner with Elon Musk on Project Colossus… Before May 1st (Ad) Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you…
To partner with Elon on what he believes will be the biggest AI project of the century…
Starting with as little as $500. Click here to see how you could take a stake in Elon’s private company… |
AAPL Apple | $222.57
+0.2% | 1/29/2025 | Downgraded by | Oppenheimer | Analyst Martin Yang | Outperform -> Market Perform | | Medium | View details for Oppenheimer rating of Apple (NASDAQ:AAPL) on 1/29/2025 |
TRNS Transcat | $74.69
+0.3% | 1/29/2025 | Downgraded by | Oppenheimer | Analyst Martin Yang | Outperform -> Market Perform | | High | View details for Oppenheimer rating of Transcat (NASDAQ:TRNS) on 1/29/2025 |
IFF International Flavors & Fragrances | $77.51
-0.1% | 1/28/2025 | Target Lowered by | Oppenheimer | Analyst Kristen Owen | Outperform -> Outperform | $117.00 -> $114.00 | Medium | View details for Oppenheimer rating of International Flavors & Fragrances (NYSE:IFF) on 1/28/2025 |
SHLS Shoals Technologies Group | $3.24
-2.6% | 1/28/2025 | Target Lowered by | Oppenheimer | Analyst Colin Rusch | Outperform -> Outperform | $11.00 -> $10.00 | Low | View details for Oppenheimer rating of Shoals Technologies Group (NASDAQ:SHLS) on 1/28/2025 |
AGCO AGCO | $93.07
+0.5% | 1/28/2025 | Target Raised by | Oppenheimer | Analyst Kristen Owen | Outperform -> Outperform | $108.00 -> $109.00 | Low | View details for Oppenheimer rating of AGCO (NYSE:AGCO) on 1/28/2025 |
AMSC American Superconductor | $18.21
+0.4% | 1/28/2025 | Target Raised by | Oppenheimer | Analyst Colin Rusch | Outperform -> Outperform | $29.00 -> $33.00 | Low | View details for Oppenheimer rating of American Superconductor (NASDAQ:AMSC) on 1/28/2025 |
BIOX Bioceres Crop Solutions | $4.47
-2.3% | 1/28/2025 | Target Lowered by | Oppenheimer | Analyst Kristen Owen | Outperform -> Outperform | $13.00 -> $12.00 | Medium | View details for Oppenheimer rating of Bioceres Crop Solutions (NASDAQ:BIOX) on 1/28/2025 |
CF CF Industries | $79.28
+1.4% | 1/28/2025 | Target Lowered by | Oppenheimer | Analyst Kristen Owen | Outperform -> Outperform | $114.00 -> $111.00 | Low | View details for Oppenheimer rating of CF Industries (NYSE:CF) on 1/28/2025 |
DE Deere & Company | $476.45
+1.5% | 1/28/2025 | Target Raised by | Oppenheimer | Analyst Kristen Owen | Outperform -> Outperform | $477.00 -> $507.00 | Low | View details for Oppenheimer rating of Deere & Company (NYSE:DE) on 1/28/2025 |
TWLO Twilio | $97.64
-0.3% | 1/24/2025 | Target Raised by | Oppenheimer | Analyst Ittai Kidron | Outperform -> Outperform | $90.00 -> $160.00 | High | View details for Oppenheimer rating of Twilio (NYSE:TWLO) on 1/24/2025 |
ADUS Addus HomeCare | $99.44
+0.6% | 1/24/2025 | Target Raised by | Oppenheimer | Analyst Ari Wald | Outperform -> Outperform | $145.00 -> $150.00 | Medium | View details for Oppenheimer rating of Addus HomeCare (NASDAQ:ADUS) on 1/24/2025 |
EVH Evolent Health | $9.71
+2.6% | 1/24/2025 | Target Lowered by | Oppenheimer | Analyst Jeff Jones | Outperform -> Outperform | $28.00 -> $18.00 | Medium | View details for Oppenheimer rating of Evolent Health (NYSE:EVH) on 1/24/2025 |
OSIS OSI Systems | $194.96
+0.3% | 1/24/2025 | Target Raised by | Oppenheimer | Analyst Christopher Glynn | Outperform -> Outperform | $205.00 -> $225.00 | Medium | View details for Oppenheimer rating of OSI Systems (NASDAQ:OSIS) on 1/24/2025 |
TDOC Teladoc Health | $7.92
-0.6% | 1/24/2025 | Target Lowered by | Oppenheimer | Analyst Michael Wiederhorn | Outperform -> Outperform | $14.00 -> $12.00 | Low | View details for Oppenheimer rating of Teladoc Health (NYSE:TDOC) on 1/24/2025 |
TOST Toast | $34.02
+2.6% | 1/24/2025 | Initiated by | Oppenheimer | Analyst Rayna Kumar | Outperform | $46.00 | High | View details for Oppenheimer rating of Toast (NYSE:TOST) on 1/24/2025 |
EXEL Exelixis | $36.50
-1.2% | 1/24/2025 | Downgraded by | Oppenheimer | Analyst Jay Olson | Outperform -> Market Perform | $41.00 -> $33.00 | High | View details for Oppenheimer rating of Exelixis (NASDAQ:EXEL) on 1/24/2025 |
LTH Life Time Group | $30.06
-0.5% | 1/23/2025 | Target Raised by | Oppenheimer | Analyst Brian Nagel | Outperform -> Outperform | $33.00 -> $43.00 | Low | View details for Oppenheimer rating of Life Time Group (NYSE:LTH) on 1/23/2025 |
NFLX Netflix | $920.87
-1.3% | 1/22/2025 | Target Raised by | Oppenheimer | Analyst Jason Helfstein | Outperform -> Outperform | $1,040.00 -> $1,150.00 | High | View details for Oppenheimer rating of Netflix (NASDAQ:NFLX) on 1/22/2025 |
TARS Tarsus Pharmaceuticals | $50.11
-2.5% | 1/22/2025 | Target Raised by | Oppenheimer | Analyst Francois Brisebois | Outperform -> Outperform | $65.00 -> $72.00 | Low | View details for Oppenheimer rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 1/22/2025 |
AGYS Agilysys | $71.59
-1.3% | 1/22/2025 | Target Lowered by | Oppenheimer | Analyst Brian Schwartz | Outperform -> Outperform | $150.00 -> $135.00 | Low | View details for Oppenheimer rating of Agilysys (NASDAQ:AGYS) on 1/22/2025 |
TTWO Take-Two Interactive Software | $208.57
+0.6% | 1/21/2025 | Target Raised by | Oppenheimer | Analyst Martin Yang | Outperform -> Outperform | $190.00 -> $215.00 | High | View details for Oppenheimer rating of Take-Two Interactive Software (NASDAQ:TTWO) on 1/21/2025 |
EA Electronic Arts | $145.18
+0.5% | 1/21/2025 | Target Lowered by | Oppenheimer | Analyst Martin Yang | Outperform -> Outperform | $170.00 -> $165.00 | Low | View details for Oppenheimer rating of Electronic Arts (NASDAQ:EA) on 1/21/2025 |
HLNE Hamilton Lane | $150.90
+1.5% | 1/21/2025 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $186.00 | High | View details for Oppenheimer rating of Hamilton Lane (NASDAQ:HLNE) on 1/21/2025 |
USB U.S. Bancorp | $41.75
-1.1% | 1/17/2025 | Target Raised by | Oppenheimer | Analyst Chris Kotowski | Outperform -> Outperform | $62.00 -> $63.00 | Low | View details for Oppenheimer rating of U.S. Bancorp (NYSE:USB) on 1/17/2025 |
BAC Bank of America | $41.43
-0.7% | 1/17/2025 | Target Raised by | Oppenheimer | Analyst Chris Kotowski | Outperform -> Outperform | $54.00 -> $55.00 | Low | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 1/17/2025 |
COIN Coinbase Global | $173.07
+0.5% | 1/17/2025 | Target Lowered by | Oppenheimer | Analyst Owen Lau | Outperform -> Outperform | $358.00 -> $334.00 | Medium | View details for Oppenheimer rating of Coinbase Global (NASDAQ:COIN) on 1/17/2025 |
ENS EnerSys | $92.33
+0.8% | 1/17/2025 | Upgraded by | Oppenheimer | Analyst Noah Kaye | Market Perform -> Outperform | $115.00 | High | View details for Oppenheimer rating of EnerSys (NYSE:ENS) on 1/17/2025 |
EXEL Exelixis | $36.50
-1.2% | 1/16/2025 | Target Raised by | Oppenheimer | Analyst Jay Olson | Outperform -> Outperform | $38.00 -> $41.00 | Low | View details for Oppenheimer rating of Exelixis (NASDAQ:EXEL) on 1/16/2025 |
KROS Keros Therapeutics | $9.74
-4.5% | 1/16/2025 | Target Lowered by | Oppenheimer | Analyst Andreas Argyrides | Outperform -> Outperform | $63.00 -> $23.00 | High | View details for Oppenheimer rating of Keros Therapeutics (NASDAQ:KROS) on 1/16/2025 |
PRO PROS | $19.06
+0.2% | 1/16/2025 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of PROS (NYSE:PRO) on 1/16/2025 |
FRSH Freshworks | $14.27
+1.1% | 1/16/2025 | Upgraded by | Oppenheimer | Analyst Brian Schwartz | Market Perform -> Outperform | $22.00 | Medium | View details for Oppenheimer rating of Freshworks (NASDAQ:FRSH) on 1/16/2025 |
MBLY Mobileye Global | $14.41
+0.1% | 1/15/2025 | Initiated by | Oppenheimer | Analyst Colin Rusch | Outperform | $28.00 | Medium | View details for Oppenheimer rating of Mobileye Global (NASDAQ:MBLY) on 1/15/2025 |
SYM Symbotic | $20.34
+0.6% | 1/15/2025 | Initiated by | Oppenheimer | Analyst Colin Rusch | Outperform | $35.00 | High | View details for Oppenheimer rating of Symbotic (NASDAQ:SYM) on 1/15/2025 |
NFLX Netflix | $920.87
-1.3% | 1/15/2025 | Target Lowered by | Oppenheimer | Analyst Jason Helfstein | Outperform -> Outperform | $1,065.00 -> $1,040.00 | Low | View details for Oppenheimer rating of Netflix (NASDAQ:NFLX) on 1/15/2025 |
S SentinelOne | $18.46
+1.5% | 1/15/2025 | Initiated by | Oppenheimer | Analyst Ittai Kidron | Outperform | $32.00 | Medium | View details for Oppenheimer rating of SentinelOne (NYSE:S) on 1/15/2025 |
ACA Arcosa | $77.54
+0.5% | 1/14/2025 | Target Raised by | Oppenheimer | Analyst Ian Zaffino | Outperform -> Outperform | $105.00 -> $110.00 | High | View details for Oppenheimer rating of Arcosa (NYSE:ACA) on 1/14/2025 |
AOS A. O. Smith | $65.36
0.0% | 1/14/2025 | Upgraded by | Oppenheimer | Analyst Bryan Blair | Market Perform -> Outperform | $88.00 | High | View details for Oppenheimer rating of A. O. Smith (NYSE:AOS) on 1/14/2025 |
CBOE Cboe Global Markets | $224.42
-0.8% | 1/13/2025 | Target Lowered by | Oppenheimer | Analyst Owen Lau | Outperform -> Outperform | $232.00 -> $218.00 | N/A | View details for Oppenheimer rating of Cboe Global Markets (NASDAQ:CBOE) on 1/13/2025 |
CLH Clean Harbors | $198.83
+0.9% | 1/13/2025 | Target Raised by | Oppenheimer | Analyst Noah Kaye | Outperform -> Outperform | $255.00 -> $256.00 | Low | View details for Oppenheimer rating of Clean Harbors (NYSE:CLH) on 1/13/2025 |
NTLA Intellia Therapeutics | $6.84
-3.9% | 1/13/2025 | Target Lowered by | Oppenheimer | Analyst Jay Olson | Outperform -> Outperform | $60.00 -> $40.00 | Medium | View details for Oppenheimer rating of Intellia Therapeutics (NASDAQ:NTLA) on 1/13/2025 |
NDAQ Nasdaq | $76.08
+0.3% | 1/13/2025 | Target Raised by | Oppenheimer | Analyst Owen Lau | Outperform -> Outperform | $86.00 -> $89.00 | Low | View details for Oppenheimer rating of Nasdaq (NASDAQ:NDAQ) on 1/13/2025 |
SNOW Snowflake | $147.67
+1.0% | 1/13/2025 | Target Raised by | Oppenheimer | Analyst Ittai Kidron | Outperform -> Outperform | $180.00 -> $200.00 | Low | View details for Oppenheimer rating of Snowflake (NYSE:SNOW) on 1/13/2025 |
CGEN Compugen | $1.44
-1.7% | 1/13/2025 | Initiated by | Oppenheimer | - | Outperform | $4.00 | High | View details for Oppenheimer rating of Compugen (NASDAQ:CGEN) on 1/13/2025 |
PRQR ProQR Therapeutics | $1.30
-2.6% | 1/10/2025 | Initiated by | Oppenheimer | - | Outperform | $15.00 | High | View details for Oppenheimer rating of ProQR Therapeutics (NASDAQ:PRQR) on 1/10/2025 |
MAS Masco | $69.62
+0.1% | 1/10/2025 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $89.00 | Low | View details for Oppenheimer rating of Masco (NYSE:MAS) on 1/10/2025 |
KRRO Korro Bio | $16.68
-4.2% | 1/10/2025 | Initiated by | Oppenheimer | - | Outperform | $155.00 | High | View details for Oppenheimer rating of Korro Bio (NASDAQ:KRRO) on 1/10/2025 |
AYI Acuity Brands | $262.18
-0.4% | 1/9/2025 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $370.00 -> $380.00 | High | View details for Oppenheimer rating of Acuity Brands (NYSE:AYI) on 1/9/2025 |
IRTC iRhythm Technologies | $104.86
+0.2% | 1/8/2025 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $105.00 -> $120.00 | High | View details for Oppenheimer rating of iRhythm Technologies (NASDAQ:IRTC) on 1/8/2025 |
BJRI BJ's Restaurants | $35.34
+3.2% | 1/7/2025 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | High | View details for Oppenheimer rating of BJ’s Restaurants (NASDAQ:BJRI) on 1/7/2025 |
CAKE Cheesecake Factory | $50.41
+3.6% | 1/7/2025 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $65.00 | Medium | View details for Oppenheimer rating of Cheesecake Factory (NASDAQ:CAKE) on 1/7/2025 |
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars (Ad) Musk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to help build human colonies on the Red Planet.
And here on Earth? Optimus is about to change everything. There's no time to waste. As far as I can tell, the best way to profit from this project is to make |
FICO Fair Isaac | $1,855.86
+0.6% | 1/7/2025 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $2,515.00 -> $2,409.00 | Medium | View details for Oppenheimer rating of Fair Isaac (NYSE:FICO) on 1/7/2025 |
JACK Jack in the Box | $27.03
-0.6% | 1/7/2025 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $52.00 | High | View details for Oppenheimer rating of Jack in the Box (NASDAQ:JACK) on 1/7/2025 |
QSR Restaurant Brands International | $67.18
+0.8% | 1/7/2025 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $86.00 -> $77.00 | Medium | View details for Oppenheimer rating of Restaurant Brands International (NYSE:QSR) on 1/7/2025 |
SEIC SEI Investments | $77.63
0.0% | 1/7/2025 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $85.00 -> $94.00 | Medium | View details for Oppenheimer rating of SEI Investments (NASDAQ:SEIC) on 1/7/2025 |
SHAK Shake Shack | $90.33
+2.5% | 1/7/2025 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $145.00 -> $155.00 | Medium | View details for Oppenheimer rating of Shake Shack (NYSE:SHAK) on 1/7/2025 |
SG Sweetgreen | $25.28
+1.0% | 1/7/2025 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $45.00 -> $41.00 | High | View details for Oppenheimer rating of Sweetgreen (NYSE:SG) on 1/7/2025 |
TRU TransUnion | $83.56
+0.7% | 1/7/2025 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $115.00 -> $112.00 | High | View details for Oppenheimer rating of TransUnion (NYSE:TRU) on 1/7/2025 |
ULTA Ulta Beauty | $372.11
+1.5% | 1/7/2025 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $505.00 -> $515.00 | High | View details for Oppenheimer rating of Ulta Beauty (NASDAQ:ULTA) on 1/7/2025 |
YUM Yum! Brands | $158.14
+0.5% | 1/7/2025 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $154.00 -> $160.00 | High | View details for Oppenheimer rating of Yum! Brands (NYSE:YUM) on 1/7/2025 |
CMG Chipotle Mexican Grill | $50.89
+1.4% | 1/7/2025 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $69.00 | Medium | View details for Oppenheimer rating of Chipotle Mexican Grill (NYSE:CMG) on 1/7/2025 |
DRI Darden Restaurants | $207.71
0.0% | 1/7/2025 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $200.00 -> $218.00 | Low | View details for Oppenheimer rating of Darden Restaurants (NYSE:DRI) on 1/7/2025 |
DENN Denny's | $3.81
+3.7% | 1/7/2025 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $8.00 | High | View details for Oppenheimer rating of Denny’s (NASDAQ:DENN) on 1/7/2025 |
DPZ Domino's Pizza | $461.38
+0.4% | 1/7/2025 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $490.00 -> $495.00 | N/A | View details for Oppenheimer rating of Domino’s Pizza (NASDAQ:DPZ) on 1/7/2025 |
ECG Everus | $37.13
+0.1% | 1/7/2025 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $70.00 -> $80.00 | N/A | View details for Oppenheimer rating of Everus (NYSE:ECG) on 1/7/2025 |
TEAM Atlassian | $212.44
+0.1% | 1/6/2025 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $270.00 -> $300.00 | N/A | View details for Oppenheimer rating of Atlassian (NASDAQ:TEAM) on 1/6/2025 |
BAC Bank of America | $41.43
-0.7% | 1/3/2025 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $57.00 -> $54.00 | N/A | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 1/3/2025 |
C Citigroup | $70.33
-0.9% | 1/3/2025 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $102.00 | N/A | View details for Oppenheimer rating of Citigroup (NYSE:C) on 1/3/2025 |
GS The Goldman Sachs Group | $546.50
+0.0% | 1/3/2025 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $677.00 -> $639.00 | N/A | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 1/3/2025 |
JEF Jefferies Financial Group | $53.12
-0.8% | 1/3/2025 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $82.00 -> $81.00 | N/A | View details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 1/3/2025 |
MCO Moody's | $467.07
+0.3% | 1/3/2025 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $543.00 -> $545.00 | N/A | View details for Oppenheimer rating of Moody’s (NYSE:MCO) on 1/3/2025 |
SPGI S&P Global | $508.95
+0.2% | 1/3/2025 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $590.00 -> $580.00 | N/A | View details for Oppenheimer rating of S&P Global (NYSE:SPGI) on 1/3/2025 |
USB U.S. Bancorp | $41.75
-1.1% | 1/3/2025 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $66.00 -> $62.00 | N/A | View details for Oppenheimer rating of U.S. Bancorp (NYSE:USB) on 1/3/2025 |
OLED Universal Display | $139.41
0.0% | 1/2/2025 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $220.00 -> $200.00 | N/A | View details for Oppenheimer rating of Universal Display (NASDAQ:OLED) on 1/2/2025 |
ROP Roper Technologies | $590.71
+0.2% | 12/23/2024 | Initiated by | Oppenheimer | - | Outperform | $630.00 | N/A | View details for Oppenheimer rating of Roper Technologies (NYSE:ROP) on 12/23/2024 |
CSL Carlisle Companies | $342.82
+0.7% | 12/20/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $505.00 -> $495.00 | N/A | View details for Oppenheimer rating of Carlisle Companies (NYSE:CSL) on 12/20/2024 |
DRI Darden Restaurants | $207.71
0.0% | 12/20/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $182.00 -> $200.00 | N/A | View details for Oppenheimer rating of Darden Restaurants (NYSE:DRI) on 12/20/2024 |
RYTM Rhythm Pharmaceuticals | $51.85
-2.1% | 12/20/2024 | Initiated by | Oppenheimer | - | Outperform | $76.00 | N/A | View details for Oppenheimer rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 12/20/2024 |
VRTX Vertex Pharmaceuticals | $484.97
+0.0% | 12/19/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | N/A | View details for Oppenheimer rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 12/19/2024 |
EEFT Euronet Worldwide | $107.37
+0.5% | 12/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $135.00 -> $128.00 | N/A | View details for Oppenheimer rating of Euronet Worldwide (NASDAQ:EEFT) on 12/19/2024 |
FI Fiserv | $221.11
+0.1% | 12/19/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $214.00 -> $239.00 | N/A | View details for Oppenheimer rating of Fiserv (NYSE:FI) on 12/19/2024 |
MA Mastercard | $546.94
-0.2% | 12/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $591.00 -> $588.00 | N/A | View details for Oppenheimer rating of Mastercard (NYSE:MA) on 12/19/2024 |
FOUR Shift4 Payments | $83.60
+2.3% | 12/19/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $120.00 -> $121.00 | N/A | View details for Oppenheimer rating of Shift4 Payments (NYSE:FOUR) on 12/19/2024 |
V Visa | $345.04
-1.5% | 12/19/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $321.00 -> $375.00 | N/A | View details for Oppenheimer rating of Visa (NYSE:V) on 12/19/2024 |
XYZ Block | $55.02
+1.3% | 12/19/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $115.00 | N/A | View details for Oppenheimer rating of Block (NYSE:XYZ) on 12/19/2024 |
ONTO Onto Innovation | $121.66
+0.3% | 12/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $275.00 -> $275.00 | N/A | View details for Oppenheimer rating of Onto Innovation (NYSE:ONTO) on 12/17/2024 |
MNMD Mind Medicine (MindMed) | $5.62
-3.9% | 12/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $20.00 -> $20.00 | N/A | View details for Oppenheimer rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 12/17/2024 |
BELFB Bel Fuse | $74.92
+0.1% | 12/17/2024 | Initiated by | Oppenheimer | - | Outperform | $105.00 | N/A | View details for Oppenheimer rating of Bel Fuse (NASDAQ:BELFB) on 12/17/2024 |
NARI Inari Medical | $79.97
| 12/17/2024 | Initiated by | Oppenheimer | - | Outperform | $75.00 | N/A | View details for Oppenheimer rating of Inari Medical (NASDAQ:NARI) on 12/17/2024 |
PEN Penumbra | $269.58
+0.8% | 12/17/2024 | Initiated by | Oppenheimer | - | Outperform | $275.00 | N/A | View details for Oppenheimer rating of Penumbra (NYSE:PEN) on 12/17/2024 |
NFLX Netflix | $920.87
-1.3% | 12/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $825.00 -> $1,065.00 | N/A | View details for Oppenheimer rating of Netflix (NASDAQ:NFLX) on 12/16/2024 |
KROS Keros Therapeutics | $9.74
-4.5% | 12/16/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $102.00 -> $63.00 | N/A | View details for Oppenheimer rating of Keros Therapeutics (NASDAQ:KROS) on 12/16/2024 |
NPO Enpro | $160.49
-0.8% | 12/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $170.00 -> $215.00 | N/A | View details for Oppenheimer rating of Enpro (NYSE:NPO) on 12/16/2024 |
CNC Centene | $60.49
-0.4% | 12/13/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $95.00 -> $85.00 | N/A | View details for Oppenheimer rating of Centene (NYSE:CNC) on 12/13/2024 |
SGHC Super Group | $6.50
+0.9% | 12/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $6.00 -> $9.00 | N/A | View details for Oppenheimer rating of Super Group (NYSE:SGHC) on 12/13/2024 |
SCI Service Co. International | $80.65
+0.6% | 12/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $86.00 -> $92.00 | N/A | View details for Oppenheimer rating of Service Co. International (NYSE:SCI) on 12/13/2024 |
WCN Waste Connections | $196.16
+0.5% | 12/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $192.00 -> $195.00 | N/A | View details for Oppenheimer rating of Waste Connections (NYSE:WCN) on 12/13/2024 |
KNF Knife River | $90.44
+0.3% | 12/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $120.00 | N/A | View details for Oppenheimer rating of Knife River (NYSE:KNF) on 12/13/2024 |
TOL Toll Brothers | $105.42
-0.2% | 12/12/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $189.00 -> $189.00 | N/A | View details for Oppenheimer rating of Toll Brothers (NYSE:TOL) on 12/12/2024 |
OWL Blue Owl Capital | $20.12
+0.4% | 12/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $24.00 -> $28.00 | N/A | View details for Oppenheimer rating of Blue Owl Capital (NYSE:OWL) on 12/12/2024 |
GCMG GCM Grosvenor | $13.24
+0.0% | 12/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $18.00 -> $20.00 | N/A | View details for Oppenheimer rating of GCM Grosvenor (NASDAQ:GCMG) on 12/12/2024 |
KKR KKR & Co. Inc. | $116.43
+0.7% | 12/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $153.00 -> $175.00 | N/A | View details for Oppenheimer rating of KKR & Co. Inc. (NYSE:KKR) on 12/12/2024 |
STEP StepStone Group | $53.10
+1.7% | 12/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $73.00 -> $84.00 | N/A | View details for Oppenheimer rating of StepStone Group (NASDAQ:STEP) on 12/12/2024 |
MOS Mosaic | $26.69
-1.2% | 12/12/2024 | Initiated by | Oppenheimer | - | Market Perform | | N/A | View details for Oppenheimer rating of Mosaic (NYSE:MOS) on 12/12/2024 |
NTR Nutrien | $49.59
-0.2% | 12/12/2024 | Initiated by | Oppenheimer | - | Outperform | $60.00 | N/A | View details for Oppenheimer rating of Nutrien (NYSE:NTR) on 12/12/2024 |
CF CF Industries | $79.28
+1.4% | 12/12/2024 | Initiated by | Oppenheimer | - | Outperform | $114.00 | N/A | View details for Oppenheimer rating of CF Industries (NYSE:CF) on 12/12/2024 |
ADBE Adobe | $379.06
-1.2% | 12/12/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $625.00 -> $600.00 | N/A | View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 12/12/2024 |
XPO XPO | $109.56
+1.8% | 12/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $148.00 -> $176.00 | N/A | View details for Oppenheimer rating of XPO (NYSE:XPO) on 12/12/2024 |
CLRB Cellectar Biosciences | $0.31
-1.4% | 12/11/2024 | Reiterated by | Oppenheimer | - | Outperform -> Market Perform | | N/A | View details for Oppenheimer rating of Cellectar Biosciences (NASDAQ:CLRB) on 12/11/2024 |
QTTB Q32 Bio | $1.58
-4.0% | 12/11/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $80.00 -> $20.00 | N/A | View details for Oppenheimer rating of Q32 Bio (NASDAQ:QTTB) on 12/11/2024 |
TRMB Trimble | $65.27
-0.6% | 12/11/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $77.00 -> $88.00 | N/A | View details for Oppenheimer rating of Trimble (NASDAQ:TRMB) on 12/11/2024 |
